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Introduction
Lower lip squamous cell carcinoma (LLSCC) is a
fairly common tumor found mostly in middle-aged
or elderly males.1,2 The prognosis for such patients
depends mainly on the clinical staging of the neo-
plasia, especially with regard to its size and to
lymph node status.3–5
A multivariate analysis of over 1000 patients with
lip carcinoma confirmed that the subgroup having
the lowest determinate survival of 61% at five-year
involved subjects with regional metastases to the
cervical lymph nodes6; these are observed at the
time of initial lip carcinoma diagnosis in 2–12% of
patients and another 3–13% will manifest nodal
metastases sometime after the initial treatment
for lip cancer.2,6 For these reasons factors evidenc-
ing the potential aggressiveness of the tumour
might be useful to identify which patients had a suf-
ficient risk of occult lymph node metastases to jus-
tify elective regional treatment.
In recent years, numerous studies have at-
tempted to identify new significant prognostic
parameters and more suitable therapeutic ap-
proaches. Interesting results have been obtained
with proteins directly and indirectly implicated in
the regulation of the cell cycle.
Cyclin D1 (CCND1), located on chromosome
11q13, encodes a critical cell cycle regulatory pro-
tein implicated in cell cycle progression from G1 to
S phase.7 Both CCND1 amplification and overex-
pression have been reported to be significantly cor-
related to aggressive tumour growth and poor
prognosis in many kinds of malignant tumours.8–10
p27Kip1 is a tumour suppressor gene located on
chromosome 12p13. It encodes a nuclear protein
which is a cdk inhibitor and inhibits the formation
of cyclin D1/cdk complexes during G0 and early
G1 phases of the cell cycle.11 This inhibits inactiva-
tion of pRb and prevents G1 to S phase transition.
Findings in several studies indicate that low, or
absent, p27Kip1 protein expression is associated
with tumour progression and a poor prognosis in
several types of cancer,12–15 and with regard to
LLSC, we ourselves previously reported that a low
expression of p27Kip1 protein is significantly associ-
ated to node metastases and to high microscopic
thickness.16Overexpression of cyclin D1 and underexpression
of p27 have been shown to predict lymph node
metastases in several malignancies 8–10,17,18; their
role in predicting lymph node metastases in LLSCC,
however, has still not been investigated. The aim
of the present study was to ascertain whether the
cyclin D1 and p27Kip1 expression status, analysed
by immunohistochemistry, might also predict the
occurrence of lymph node metastases in surgically
treated LLSCC patients, independently of other
known predictive factors.Materials and methods
Clinical and pathologic findings
We considered a group of 122 consecutive pa-
tients who underwent radical surgical resection of
primary LLSCC between January 1st 1988 and
December 31st 1998; tissue samples taken from the
subjects and stored in the archives of the Institute
of Pathologic Anatomy and Histology of the Univer-
sity of Palermo provided adequate histological mate-
rial. Complete excision of the primary mass was
ascertained through histological examination of the
resected margins. The patients were followed up
for at least five years after surgery, at 4-monthly
intervals for the first year, 6-monthly intervals for
the second and third years and annually thereafter.
Nine patients were excluded because of histologi-
cally confirmed node metastases at the time of pri-
mary surgery. Sixteen patients were excluded
because of insufficient follow-up. A total of 97 sub-
jects (94 men and three women), who did not
undergo elective neck dissection after palpation,
ultrasound or computed tomography had shown no
signs of any lymph node metastases, were recruited
into the 60-month disease-free survival study.
Tumour size was measured in mm and then clas-
sified as T1, T2 and T3, according to the TNM
system.19Histology
All the tissue samples were fixed in 10% buf-
fered formalin, dehydrated in ethanol and
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nique. Sections 5lm thick were cut and stained
with H&E, PAS, Alcian blue and Massons trichrome.
They were reassessed with regard to histological
grading and classified as G1, G2, G3 and G4, follow-
ing the method recommended by Anneroth and
Hansen.20 Inspection for the possible presence of
perineural invasion, reported as present or absent,
was performed on each sample. The measurement
of microscopic thickness was performed with a 2.5
magnifying lens by an image analysis system (Leica
QM500, Cambridge, UK) and the resulting software
processing was expressed in mm as previously
described.16Immunohistochemistry
The avidin–biotin peroxidase complex tech-
nique was used on 5lm sections of formalin-fixed,
paraffin-embedded tissues after deparaffinization
as previously described.16 Briefly, the sections
were reacted consecutively with monoclonal anti-
body K25020 (Transduction laboratories, Lexing-
ton, KY, USA) generated from mouse p27(Kip1)
protein at a concentration of 1:1.200 or, to detect
cyclin D1, with mouse monoclonal antibody DCS-6
(DAKO, Glostrup, Denmark) at a dilution of 1:50
at 4 C overnight.
Biotinylated alpha mouse IgG obtained from
horse serum (ABC Kit, Vector Laboratories, Burlin-
game, CA) was applied as a secondary antibody at
1:400 in PBS for 30min at room temperature.
Immunostaining was performed using the avidin–
biotin peroxidase complex technique (ABC Kit,
Vector Laboratories) applied for 30min. Finally,
3,3-diaminobenzidine tetrahydrochloride (DAKO,
Glostrup, Denmark) in distilled water was used as
the chromogen for 10min, and sections were coun-
terstained using Mayers hematoxylin.
The grade of p27Kip1 protein expression in each
specimen was evaluated according to the percent-
age of positively stained cells among the total num-
ber of counted cancer cells; all positive cells were
counted regardless of intensity of staining and used
as labeling index (LI). Cyclin D1 expression was
assessed on both the intensity of nuclear staining
within the tumour cells and the percentage of cells
that were positive. Cytoplasmic staining was not
regarded as positive expression. In general, tu-
mours that showed strong nuclear cyclin D1 expres-
sion also showed diffuse distribution of positive
cells within the tumour. These tumours were re-
garded as positive expressers of cyclin D1. Tumours
that were negative expressers of cyclin D1 gener-
ally showed no cyclin D1 immunoreactivity at all.Tumours were divided into two groups, namely
expressers of cyclin D1 and non-expressers of cyclin
D1.
Statistical methods
Age of patients, tumour size, maximal thickness,
histological grading, perineural invasion, cyclin D1
expression and p27Kip1 LI were investigated as pre-
dictive factors for lymph node metastases. Since
there were only three women patients in the
group, the effect of gender was not investigated.
The 5-year (60 months) disease-free survival rates
were calculated using the Kaplan–Meier method
and log-rank test.
Univariate and multivariate Cox proportional
hazard regression models were used to estimate
the effect of assumed predictive factors on the
hazard of lymph node metastases within 60 months
after primary surgery and 95% confidence interval
(95% CI). To find a parsimonious model that ade-
quately fits the data, backward stepwise procedure
was used setting the significance criteria at
P = 0.05 for variable inclusion in the final multivar-
iate model and P = 0.1 for removal. Continuous
variables were entered into Cox models either as
such or as categorical parameter. Age of patients
was categorised as \60 years, 60–70 years, [70
years; because there were very few tumours in
class T3, we chose to dichotomise size by pooling
classes T2 and T3; histologic grading was dichoto-
mised as G1 and G2 vs G3 and G4; tumour thickness
was dichotomised on the basis of the third quartile
(5mm); cut-off point for dichotomising the per-
centage of neoplastic cells expressing p27Kip1 was
arbitrarily set at 20%.
To evaluate whether the risk of lymph node
metastases was modified by interactions between
the effect of cyclin D1 expression, p27Kip1 LI,
tumour size, maximal thickness, histological grading,
and perineural invasion, the first level interaction
term between pairs of variables was entered into
separate multivariate Cox models.
The proportional hazards assumption was tested
and proved not to be violated. Statistical
two-tailed significance was set at P = 0.05. All anal-
yses were performed with SPSS software (release
8.0; Chicago, IL, USA, 1997).Results
The age of the 97 study patients, 3.1% female,
ranged from 47 years to 88 years. (mean 67.3
years). Table 1 summarises the clinicopathological
Table 1 Summary of clinicopathologic parameters
in 97 lower lip squamous cell carcinomas
Parameter No. of patients (%)
Sex
Male 94 (96.9)
Female 3 (3.1)
Age (year)
\60 18 (18.6)
60–70 20 (20.6)
[70 59 (60.8)
Size
T1 80 (82.5)
T2 11 (11.3)
T3 6 (6.2)
Histologic grade
G1 11 (11.3)
G2 50 (51.6)
G3 27 (27.8)
G4 9 (9.3)
Maximal thickness
65mm 73 (75.3)
[5mm 24 (24.7)
Perineural invasion
Absent 93 (95.9)
Present 4 (4.1)
Cyclin D1 protein expression
Positive 65 (67.0)
Negative 32 (33.0)
p27Kip1 protein expression
LI P 20% 77 (79.4)
LI\20% 20 (20.6)
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The depth of neoplastic invasion ranged from 1.16
to 17.45mm (mean 4.73mm ± 3.14 standard devia-
tion); tumour size ranged from 3mm to 51mm
(mean 16.05mm ± 11.07 standard deviation). The
median percentage of tumour cells with p27Kip1
protein expression was 26.47% (range 0–94.50%).
Thirteen (13.40%) of the 97 patients subjected
to follow-up developed late lymph node metasta-
ses. The overall 5-year (60 months) disease-free
survival rate was therefore 86.60%.
Univariate analysis
Univariate Cox regression modelling (continuous
variables as such) showed all the variables investi-
gated, except patients age, to be significant pre-
dictive factors for lymph node metastases risk.
Similar results were obtained by testing continuous
variables converted to categories (Table 2).
Multivariate analysis
Tests of the effect of interaction between pairs
of variables on the hazard of lymph node metasta-
ses yielded significant results only for p27Kip1 LI by
tumour thickness as continuous (P = 0.002) as well
as categorised (P = 0.046) variables. The effect of
the interaction between p27Kip1 LI and tumour
thickness on mean time of disease-free survival is
shown in Fig. 1. Patients with a tumour thicknessTable 2 Univariate Cox regression models for predictors of lymph node metastasis with converted to categories
and continuous variables
Categorised
variables
Estimated
hazard ratio
95% CI Pa Continuous
Variables
Estimated
hazard
ratio
95% CI Pa
Lower Upper Lower Upper
Tumor size
(T2–3 vs T1)
15.21 2.25 94.18 0.0033 Tumor
size (mm)
1.09 1.05 1.13 \0.0001
Maximal thickness
([5mm vs 65mm)
13.17 3.61 48.02 0.0001 Maximal
thickness
(mm)
1.32 1.18 1.48 \0.0001
p27Kip1 LI
(LI\20%
vs LI P 20%)
9.37 0.02 0.27 \0.0001 p27Kip1 LI
(%)
0.92 0.89 0.96 \0.0001
Perineural invasion
(present vs absent)
9.78 2.64 36.27 0.0006
Cyclin D1 expression
(positive vs negative)
7.94 2.18 28.90 0.0017
Histologic grading
(G3–4 vs G1–2)
3.51 1.15 10.75 0.028
a Wald test.
272 V. Rodolico et al.[5mm and p27Kip1 LI\20% have a disease-free
survival (37 months, 95% CI:24-49) significantly
(P = 0.039) lower than patients whose tumour
thickness is 65mm and p27Kip1 LI P 20% (59
months, 95% CI:58-61).
The backward stepwise procedure applied to a
Cox proportional hazards regression model, ini-
tially including statistically significant continuous
variables as such in univariate analyses and the
interaction term between p27Kip1 LI and tumour
thickness, identified only tumour size, positive
Cyclin D1 protein expression, percentage of
p27Kip1 positive tumour cells and the interaction
term between p27Kip1 LI and tumour thickness asTable 3 Multivariate Cox proportional hazards regression
with continuous (model no. 1) and converted to categories
Estimated
Model no. 1
Tumour size (mm) 1.04
Cyclin D1 expression (positive vs negative) 13.13
p27Kip1 LI (%) 0.70
p27Kip1 LI (%) by maximal thickness (mm) 1.03
Maximal thickness (mm) 0.96
Model no. 2
Tumor size (T2–3 vs T1) 13.50
Cyclin D1 expression (positive vs negative) 4.83
Maximal thickness ([5mm vs 65mm) 10.93
p27Kip1 LI (LI\20% vs LI P 20%) 2.28
a Wald test.
Figure 1 Mean time of metastatic events according to
percentage of p27Kip1 positive tumoural cells and tumour
thickness for 97 lower lip squamous cell carcinoma
patients.significant independent predictors of lymph node
metastases (Table 3, model no. 1). The Wald test
results on tumour thickness was not significant
(P = 0.072); the likelihood ratio test, however,
showed that when tumour thickness was removed
a significant decrease in fit occurred; i.e. tumour
thickness was needed in the model. A lower per-
centage of p27Kip1 LI, a larger grade of tumour
thickness and size together with the expression of
cyclin D1 in tumour cells, led to a higher risk of
lymph node metastases.
Backward stepwise multivariate Cox regression
analysis was also carried out using the six categor-
ical and categorised continuous variables statisti-
cally significant in univariate analyses (Table 3,
model no. 2). Once more tumour size [T2 and T3
vs T1: HR = 13.50 (95% CI: 2.19–83.06; P = 0.005)]
and cyclin D1 [present vs absent: HR = 4.83 (95%
CI: 0.99–23.37; P = 0.0195)] were retained in the
final model that now included tumour thickness
[ 5mm vs 65mm: HR = 10.93 (95% CI: 2.11–
56.44; P = 0.0043)] as significant independent pre-
dictors of lymph node metastases. The p27Kip1 LI
result of the Wald test, in fact, was not significant
(P = 0.069); as for tumour thickness in the previous
Cox model, however, p27Kip1 LI was also needed in
this model.Discussion
In this study, we have attempted to identify
those subgroups of patients most likely to develop
lymph node metastases from squamous cell carci-
noma of the lower lip, to identify which patientsmodel for predictors of lymph node metastasis: models
(model no. 2) variables
hazard ratio 95% CI Pa
Lower Upper
0.99 1.09 0.04236
1.77 91.89 0.0195
0.57 0.88 0.0019
1.01 1.06 0.0053
0.74 1.25 0.072
2.19 83.06 0.005
0.99 23.37 0.0195
2.11 56.44 0.0043
0.47 11.09 0.069
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metastases to justify elective regional treatment.
In this assessment of lymph node metastases
predictors, we included five clinical and histopa-
thological parameters (patient age, tumour size,
histological grading, maximal thickness, perineural
invasion) reported to be important predictors for
survival in LLSSC; we hypothesised that the same
factors might also predict the metastatic potential
of such tumours. Finally, we included tumour
immunoreactivity to cyclin D1 and p27Kip1 proteins
based on the findings in other cancers.
After univariate analysis all the variables investi-
gated, except patients age, proved to be signifi-
cant factors for lymph node metastases risk.
Tests of the effect of interaction between p27Kip1
LI and tumour thickness yielded that the impact
of tumour thickness on the risk of lymph node
metastases was modified by the percentage of
p27Kip1 positive cells. Subsequent to both models
of multivariate analysis, including continuous and
categorical variables, histological grading and per-
ineural invasion lost their significance as predictors
of lymph node metastases. However, tumour size,
positive cyclin D1 protein expression, maximal
thickness ([5mm), p27Kip1 LI (%) and the interac-
tion term between p27Kip1 LI and tumour thickness
retained strong independent predictive values for
lymph node metastases.
Studies in oral cancer at various subsites and
stages have suggested that tumour thickness was
a predictor of nodal metastasis and poor out-
come,21–23 although contrasting results have been
reported.24 Recent studies regarding the carcinoma
of the tongue have demonstrated that tumour
thickness was the powerful predictive factor for
postoperative cervical nodal metastasis and dis-
ease-free survival.22 There are only a few studies
concerning tumour thickness in LLSCC. Onercl
et al. found a cut-off at a tumour thickness of
5mm above which the cervical lymph node metas-
tasis rate was significantly increased.25 Frierson
and Cooper, using a cut-off of 6mm of invasion,
identified lymph node metastases in 75% compared
to 4% of tumours measuring less than 6mm.4 In the
present study we show that a tumours thickness
[5mm has a significant independent predictive va-
lue for the occurrence of postoperative lymph node
metastases in LLSCC.
We obtained intriguing results with regard to
interaction between p27Kip1 LI and tumour thick-
ness on the hazard of lymph node metastases; the
data observed suggest that the diminution of the
percentage of p27Kip1 positive tumour cells is a
more powerful predictor of node metastases in pa-
tients who had greater tumour thickness than inthose of small thickness. In other words, the effect
of thickness on the hazard of lymph node metasta-
ses depends on the percentage of p27Kip1 positive
tumour cells. The discrepancy observed between
the two multivariate Cox models might depend on
the loss of information occurring at times when
continuous variables are converted into categories.
Though absent or low expression of p27Kip1 protein
has been shown to indicate poor prognosis for many
tumours, the precise biological role of p27Kip1 in
human tumours is still unclear. We previously
reported an inverse correlation between p27Kip1
protein expression and microscopic thickness in
LLSSC.16 In the present study, we found that a
low percentage of p27Kip1 positive tumour cells also
represents a significant independent predictor of
lymph node metastases occurrence.
It has been shown that patients with colorec-
tal,17 breast,14 prostate,15 or non-small cell lung
cancer12 with low or absent p27Kip1 protein expres-
sion had a poor prognosis. It has been reported that
p27Kip1 expression had independent prognostic va-
lue in primary human colorectal carcinomas and
that carcinomas with low or absent p27Kip1 protein
displayed enhanced proteolytic activity specific for
p27Kip126; this suggested that low p27Kip1 expression
may result from increased proteosome mediated
degradation rather than altered gene expression.
Several studies have suggested that p27Kip1 may
have additional functions such as cell–cell adhe-
sion.27,28 Thomas et al. have observed a reduction
of p27Kip1 expression in metastasis of colorectal
carcinoma compared to primitive tumours.17 These
findings may indicate that loss of p27Kip1 expression
confers to tumour epithelial cells the ability to sur-
vive without anchorage and provide the tumour
cells the opportunity to invade any tissue and to
develop metastases.
As to cyclin D1 expression in LSCC, Fabbrocini
et al. reported a 45.7% protein positivity incidence
in a series of LLSCC compared to 0% of controls.29
In own our series of LLSCC we observed a 67% cyclin
D1 protein positivity; moreover multivariate analy-
sis identified a significant independent predictive
value for lymph node metastases occurrence.
Although the contribution of CCND1 gene ampli-
fication to overexpression on aggressive malignant
phenotype has been well documented,8 other likely
mechanisms include up-regulation of receptor and
signalling pathways that converge on cyclin D1
gene expression.30 Recent evidence that levels of
TGF and EGFR are independent predictors of out-
come in patients with head and neck squamous cell
carcinomas (HNSCC) raises the interesting possibil-
ity that part of this effect may be mediated via in-
creased expression of cyclin D1.31 Overexpression
274 V. Rodolico et al.of cyclin D1 shortens the G1 phase and reduces
dependence on growth factors, which in turn may
result in loss of cell cycle control and increased cell
proliferation. However, in vivo infusion of iodode-
oxyuridine used as a measure of cell proliferation
in a series of HNSCC, showed no correlation
between cyclin D1 expression and cell pro-
liferation.32
In conclusion, the present study identifies tu-
mour size, maximal thickness, underexpression of
p27Kip1, overexpression of cyclin D1 and interaction
between p27Kip1 LI and tumour thickness as signifi-
cant independent predictors of lymph node metas-
tases in LLSSC. Although tumour size and maximal
thickness have previously been identified as impor-
tant factors associated with lymph node metasta-
ses, this is the first report linking the interaction
between p27Kip1 protein and tumour thickness,
the overexpression of cyclin D1 and the underex-
pression of p27Kip1 to lymph node metastases
occurrence in LLSSC. Immunohistochemistry for cy-
clin D1 and p27Kip1 can be used in routine diagnosis
and even on biopsy material prior to surgery and is
suitable for use in the selection of a high-risk sub-
group of patients who might benefit from a more
aggressive therapeutic approach; these variables
may prove to be valuable ancillary tests for identi-
fying LLSSC with metastatic potential.Acknowledgement
This work was supported by Grants from the Min-
istero dell’Istruzione dell’Universita` e della Ricerca
(MIUR) 60%.References
1. Hendricks JL, Mendelson BC, Woods JE. Invasive carcinoma
of the lower lip. Surg Clin North Am 1977;57(4):837–44.
2. Baker SR, Krause CJ. Carcinoma of the lip. Laryngoscope
1980;90(1):19–27.
3. Nuutinen J, Karja J. Local and distant metastases in
patients with surgically treated squamous cell carcinoma
of the lip. Clin Otolaryngol 1981;6(6):415–9.
4. Frierson Jr HF, Cooper PH. Prognostic factors in squamous
cell carcinoma of the lower lip. Hum Pathol 1986;17(4):
346–54.
5. Moore C, Flynn MB, Greenberg RA. Evaluation of size in
prognosis of oral cancer. Cancer 1986;58(1):158–62.
6. Zitsch RP, Park CW, Renner GJ, Rea JL. Outcome analysis
for lip carcinoma. Otolaryngol Head Neck Surg
1995;113(5):589–96.
7. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ,
Arnold A. The cyclins and cyclin-dependent kinase inhibitors
in hormonal regulation of proliferation and differentiation.
Endocr Rev 1999;20(4):501–34.8. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1
gene amplification correlates with messenger RNA overex-
pression and tumor progression in human laryngeal carci-
nomas. Cancer Res 1994;54(17):4813–7.
9. Capaccio P, Pruneri G, Carboni N, et al. Cyclin D1 protein
expression is related to clinical progression in laryngeal
squamous cell carcinomas. J Laryngol Otol 1997;111(7):
622–6.
10. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiy-
ama S. Cyclin D1 overexpression in primary hypopharyngeal
carcinomas. Cancer 1996;78(3):390–5.
11. Sgambato A, Cittadini A, Faraglia B, et al. Multiple function
of p27kip1 and its alterations in tumor cells: a review. J Cell
Physiol 2000;183(1):18–27.
12. Ishihara S, Minato K, Hoshino H, et al. The cyclin-dependent
kinase inhibitor p27 as a prognostic factor in advanced non
small cell lung cancer: its immunohistochemical evaluation
using biopsy specimens. Lung Cancer 1999;26(3):187–94.
13. Kudo Y, Takata T, Yasui W, et al. Reduced expression of
cyclin-dependent kinase inhibitor p27Kip1 is an indicator of
malignant behavior in oral squamous cell carcinoma. Cancer
1998;83(12):2447–55.
14. Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased
levels of the cell-cycle inhibitor p27Kip1 protein: prognostic
implications in primary breast cancer. Natl Med
1997;3(2):227–30.
15. Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclin-
dependent kinase inhibitor p27Kip1 is a novel prognostic
factor in localized human prostate adenocarcinoma. Cancer
Res 1998;58(3):542–8.
16. Rodolico V, Barresi E, Di Lorenzo R, et al. Lymph node
metastasis in lower lip squamous cell carcinoma in relation
to tumoursize, histologic variables and p27Kip1 protein
expression. Oral Oncol 2004;40(1):92–8.
17. Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda
M. Down-regulation of p27 is associated with development
of colorectal adenocarcinoma metastases. Am J Pathol
1998;153(8):681–7.
18. Kim DH, Lee HI, Nam ES, et al. Reduced expression of the
cell-cycle inhibitor p27Kip1 is associated with progression
and lymph node metastasis of gastric carcinoma. Histo-
pathology 2000;36(3):245–51.
19. Sobin LH, Wittekind C, editors. UICC TMN classification of
malignant tumours. 6th ed. New York: Wiley and Sons;
2002.
20. Anneroth G, Hansen LS. A methodologic study of histologic
classification and grading of malignancy in oral squamous
cell carcinoma. Scand J Dent Res 1984;92(5):448–68.
21. O-charoenrat P, Pillai G, Patel S, et al. Tumour thickness
predicts cervical nodal metastases and survival in early oral
tongue cancer. Oral Oncol 2003;39(4):386–90.
22. Asakage T, Yokose T, Mukai K, et al. Tumor thickness
predicts cervical metastasis in patients with stage I/II
carcinoma of the tongue. Cancer 1998;82(8):1443–8.
23. Martinez-Gimeno C, Rodriguez EM, Vila CN, Varela CL.
Squamous cell carcinoma of the oral cavity—a clinicopath-
ologic scoring system for evaluating risk of cervical lymph
node metastasis. Laryngoscope 1995;105(7Pt1):728–
733.
24. Yamazaki H, Inoue T, Teshima T, et al. Tongue cancer
treated with brachytherapy: is thickness of tongue cancer a
prognostic factor for regional control. Anticancer Res
1998;18(2B):1261–5.
25. Onercl M, Yilmaz T, Gedikoglu G. Tumor thickness as a
predictor of cervical lymph node metastasis in squamous
cell carcinoma of the lower lip. Otolaryngol Head Neck Surg
2000;122(1):139–42.
Overexpression of cyclin D1 and interaction between p27Kip1 and tumour 27526. Loda M, Cukor B, Tam SW, et al. Increased proteasomede-
pendent degradation of the cyclin-dependent kinase inhib-
itor p27 in aggressive colorectal carcinomas. Natl Med
1997;3(2):231–3.
27. St Croix B, Florenes VA, Rak JW, et al. Impact of the cyclin-
dependent kinase inhibitor p27Kip1 on resistance of tumor
cells to anticancer agents. Natl Med 1996;2(11):1204–10.
28. Fang F, Orend G, Watanabe N, et al. Dependence of cyclin
ECDK2 kinase activity on cell anchorage. Science
1996;271(5248):499–502.
29. Fabbrocini G, Russo N, Pagliuca MC, et al. p53, cyclin-D1,
PCNA, AgNOR expression in squamous cell cancer of the lip:a multicenter study. Photodermatol Photoimmunol
Photomed 2000;16(4):172–7.
30. Weinberg RA. The retinoblastoma protein and cell cycle
control. Cell 1995;81(3):323–30.
31. Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of
TGF- and EGFR protein in head and neck squamous cell
carcinoma and patient survival. J Natl Cancer Inst
1998;90(11):824–32.
32. Kotelnikov VM, Coon JS, Mundle S, et al. Cyclin D1 expres-
sion in squamous cell carcinomas of the head and neck and
in oral mucosa in relation to proliferation and apoptosis.
Clin Cancer Res 1997;3(1):95–101.
